Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Most individuals do not start at the maximum dose
This creates a common clinical dilemma: should a provider prescribe for the diabetes indication (easier prior authorization, fewer step therapy requirements) or the obesity indication (more appropriate for the patient's primary concern)
For example, a case study might detail a patient who, after struggling with uncontrolled diabetes and obesity for years, experienced substantial improvements in glycemic control and a notable reduction in weight within months of starting Semaglutide
Loading: 1-2 mg daily subcutaneous for 7-10 days
US$ 20.58
US$ 28.71
US$ 28.89
US$ 29.00
US$ 23.97
US$ 21.27
US$ 25.72
US$ 21.83
US$ 20.50
US$ 20.82
